Search This Blog

Monday, July 29, 2019

Zimmer Biomet upped to Outperform from Neutral by Baird

Target to $154 from $132
Posted by at No comments:

ResMed upped to Buy from Neutral by UBS

Target to $140 from $122
Posted by at No comments:

Ra Pharma cut to Market Perform from Strong Buy by Raymond James

https://www.benzinga.com/stock/RARX/ratings
Posted by at No comments:

Myriad cut to Hold from Strong Buy by Needham

https://www.benzinga.com/stock/MYGN/ratings
Posted by at No comments:

NovoCure upped to Buy from Hold by SunTrust

https://www.benzinga.com/stock/NVCR/ratings
Posted by at No comments:

Kezar started at Buy by Wainwright

Target $15
Posted by at No comments:

KalVista started at Outperform by SVB Leerink

Target $31
Posted by at No comments:
Subscribe to: Posts (Atom)